Alfredo Berruti Selected Research

Alfredo Berruti Research Topics

Disease

100	Neoplasms (Cancer) 02/2024 - 06/2002
57	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 01/2002
54	Adrenocortical Carcinoma 10/2023 - 09/2005
51	Breast Neoplasms (Breast Cancer) 04/2024 - 06/2002
19	Neoplasm Metastasis (Metastasis) 04/2023 - 01/2002
14	Disease Progression 11/2023 - 01/2002
12	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2023 - 12/2008
11	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023 - 02/2008
9	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 06/2013
8	Carcinoma (Carcinomatosis) 03/2023 - 09/2002
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 07/2004
6	Hypertension (High Blood Pressure) 02/2024 - 03/2014
6	Hypoxia (Hypoxemia) 10/2017 - 08/2006
5	Lung Neoplasms (Lung Cancer) 01/2023 - 08/2013
5	Melanoma (Melanoma, Malignant) 07/2020 - 04/2014
4	Asthenia 02/2024 - 12/2017
4	Pain (Aches) 02/2024 - 12/2018
4	Carcinoid Tumor (Carcinoid) 06/2023 - 12/2017
4	Restless Legs Syndrome (Restless Legs) 12/2022 - 05/2010
4	Adenocarcinoma of Lung 06/2021 - 09/2017
3	Nausea 04/2024 - 04/2015
3	Diarrhea 04/2024 - 04/2019
3	Weight Loss (Weight Reduction) 12/2023 - 02/2008
3	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2023 - 09/2020
3	Adenocarcinoma 09/2022 - 01/2019
3	COVID-19 09/2022 - 12/2020
3	Cushing Syndrome 01/2022 - 04/2014
3	Insulinoma 01/2021 - 01/2014
3	Anemia 01/2021 - 07/2013
3	Osteonecrosis (Kienbock's Disease) 01/2013 - 08/2009
2	Vomiting 04/2024 - 01/2022

Drug/Important Bio-Agent (IBA)

33	Mitotane (Lysodren)FDA Link 10/2023 - 09/2005
25	AndrogensIBA 04/2024 - 01/2002
21	Hormones (Hormone)IBA 10/2023 - 02/2003
14	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 10/2002
13	Biomarkers (Surrogate Marker)IBA 09/2022 - 08/2006
12	Aromatase InhibitorsIBA 01/2024 - 04/2007
10	Etoposide (VP 16)FDA LinkGeneric 09/2023 - 01/2005
10	Androgen Receptors (Androgen Receptor)IBA 04/2023 - 07/2010
10	Everolimus FDA Link 09/2022 - 01/2014
10	Epirubicin (Ellence)FDA LinkGeneric 10/2017 - 10/2002
9	Gemcitabine FDA Link 01/2021 - 08/2003
8	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2023 - 09/2005
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 08/2006
8	Abiraterone AcetateIBA 11/2019 - 11/2013
8	Estrogen ReceptorsIBA 04/2019 - 08/2006
8	AnthracyclinesIBA 01/2017 - 01/2005
7	Immune Checkpoint InhibitorsIBA 01/2024 - 09/2019
7	abirateroneIBA 01/2019 - 01/2011
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2007
7	Zoledronic Acid (Zometa)FDA Link 03/2016 - 02/2003
6	Testosterone (Sustanon)FDA Link 01/2023 - 12/2008
6	Tyrosine Kinase InhibitorsIBA 01/2023 - 09/2017
6	Diphosphonates (Bisphosphonates)IBA 11/2022 - 08/2009
6	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2021 - 01/2002
6	Tamoxifen FDA LinkGeneric 01/2021 - 08/2006
6	Letrozole (Femara)FDA LinkGeneric 05/2015 - 09/2002
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2015 - 08/2006
5	Denosumab FDA Link 01/2024 - 06/2011
5	Progesterone FDA LinkGeneric 04/2023 - 12/2016
5	PlatinumIBA 01/2022 - 07/2004
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2021 - 01/2014
5	NivolumabIBA 01/2020 - 01/2018
5	Chromogranin AIBA 05/2015 - 02/2007
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 07/2004
5	Fluorouracil (Carac)FDA LinkGeneric 06/2010 - 01/2005
4	Sunitinib (Sutent)FDA Link 02/2024 - 01/2019
4	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 01/2015
4	Docetaxel (Taxotere)FDA Link 01/2021 - 04/2008
4	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 06/2011
4	MineralocorticoidsIBA 09/2020 - 12/2013
4	Prednisone (Sone)FDA LinkGeneric 08/2019 - 03/2014
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 01/2009
4	Vitamin D FDA LinkGeneric 10/2016 - 01/2002
4	Vinorelbine (Navelbine)FDA LinkGeneric 02/2005 - 08/2003
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2019
3	TrabectedinIBA 01/2023 - 08/2018
3	ErbB Receptors (EGF Receptor)IBA 06/2021 - 11/2008
3	palbociclibIBA 01/2021 - 01/2018
3	Capecitabine (Xeloda)FDA Link 01/2021 - 06/2010
3	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2019 - 04/2014
3	GlucocorticoidsIBA 08/2019 - 01/2017
3	SteroidsIBA 10/2018 - 03/2014
3	2,2- (2- chlorophenyl- 4'- chlorophenyl)- 1,1- dichloroetheneIBA 11/2017 - 06/2011
3	2,2- (2- chlorophenyl- 4'- chlorophenyl)acetic acidIBA 11/2017 - 06/2011
3	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 11/2017 - 06/2012
3	Messenger RNA (mRNA)IBA 01/2017 - 01/2007
3	Thymidylate SynthaseIBA 01/2017 - 02/2008
3	Octreotide (Sandostatin)FDA LinkGeneric 12/2014 - 11/2009
3	Carbonic Anhydrase IXIBA 02/2011 - 09/2006
2	sacituzumab govitecanIBA 04/2024 - 01/2023

Therapy/Procedure

107	Therapeutics 04/2024 - 01/2002
48	Drug Therapy (Chemotherapy) 02/2024 - 06/2002
20	Castration 04/2023 - 11/2013
12	Immunotherapy 11/2023 - 02/2009
5	Radiotherapy 01/2023 - 04/2013
5	Adjuvant Chemotherapy 08/2022 - 01/2021
5	Aftercare (After-Treatment) 10/2021 - 08/2006
5	Prostatectomy (Retropubic Prostatectomy) 04/2021 - 04/2012
5	Neoadjuvant Therapy 05/2015 - 08/2006